Bioorganic and Medicinal Chemistry Letters p. 2963 - 2968 (1999)
Update date:2022-08-03
Topics:
Halmos, Therese
Turek, Joseph W.
Le Breton, Guy C.
Antonakis, Kostas
SQBAzide, a biotinylated, azido derivative of the TXA2 receptor antagonist, SQ31,491, was synthesized and characterized. The compound specifically inhibited human platelet aggregation mediated by TXA2 receptor activation and irreversibly labeled platelet TXA2 receptors upon exposure to ultraviolet light. This probe should prove to be of significant value for the study of the receptor-ligand binding domain.
View MoreContact:+1-416-493-6870
Address:Toronto, Canada
Contact:0571-
Address:zhejing
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Zhejiang Haizhou Pharmaceutical Co., Ltd.
website:https://www.haizhoupharma.com/
Contact:+86-576-88221016
Address:No. 19, Donghai 5th Avenue, Yanhai Industrial Zone, Linhai, Zhejiang, China
Contact:13357117572
Address:No.149 Shiji dadao Road.
Doi:10.1002/ejoc.200600944
(2007)Doi:10.1002/1099-0682(200107)2001:7<1801::AID-EJIC1801>3.0.CO;2-X
(2001)Doi:10.1021/op030039z
(2004)Doi:10.1139/v71-150
(1971)Doi:10.1021/jm00288a016
(1971)Doi:10.1039/j39700000298
(1970)